G. Mickisch

3.3k total citations · 1 hit paper
90 papers, 2.5k citations indexed

About

G. Mickisch is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, G. Mickisch has authored 90 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Pulmonary and Respiratory Medicine, 36 papers in Molecular Biology and 36 papers in Oncology. Recurrent topics in G. Mickisch's work include Renal cell carcinoma treatment (35 papers), Drug Transport and Resistance Mechanisms (21 papers) and Bladder and Urothelial Cancer Treatments (20 papers). G. Mickisch is often cited by papers focused on Renal cell carcinoma treatment (35 papers), Drug Transport and Resistance Mechanisms (21 papers) and Bladder and Urothelial Cancer Treatments (20 papers). G. Mickisch collaborates with scholars based in Netherlands, Germany and United States. G. Mickisch's co-authors include Hendrik Van Poppel, Richard Sylvester, Cathy Tangen, Robert C. Flanigan, E. David Crawford, J.P. van Brussel, Ira Pastan, P. Alken, Fritz H. Schröder and Glenn Merlino and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

G. Mickisch

83 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cytoreductive Nephrectomy in Patients With Metastatic Renal Cancer: A Combined Analysis

2004 605 citations G. Mickisch, Richard Sylvester et al. The Journal of Urology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
G. Mickisch Netherlands	25	1.3k	1.2k	963	539	505	90	2.5k
Jong Gwang Kim South Korea	33	1.1k 0.8×	769 0.6×	1.5k 1.5×	599 1.1×	590 1.2×	203	3.4k
Roberto Sorio Italy	26	915 0.7×	560 0.5×	1.7k 1.7×	613 1.1×	533 1.1×	129	3.6k
Jennifer L. Spratlin Canada	24	1.4k 1.1×	1.2k 1.0×	2.0k 2.0×	433 0.8×	767 1.5×	92	3.6k
Kees Smid Netherlands	29	1.5k 1.1×	606 0.5×	1.7k 1.8×	316 0.6×	506 1.0×	90	3.1k
Lindsey Gumbrell United Kingdom	17	932 0.7×	564 0.5×	1.3k 1.3×	392 0.7×	274 0.5×	24	2.7k
Paul Noordhuis Netherlands	32	1.4k 1.1×	506 0.4×	1.7k 1.7×	235 0.4×	412 0.8×	82	3.4k
Linda Janisch United States	23	1.7k 1.3×	738 0.6×	2.1k 2.2×	257 0.5×	400 0.8×	68	3.6k
C.J. van Groeningen Netherlands	28	983 0.8×	483 0.4×	1.4k 1.4×	279 0.5×	288 0.6×	51	2.4k
C.L. van der Wilt Netherlands	25	1.2k 0.9×	508 0.4×	1.6k 1.7×	257 0.5×	342 0.7×	60	2.7k
Albert Abad Spain	28	1.2k 0.9×	1.6k 1.3×	2.5k 2.5×	489 0.9×	565 1.1×	84	4.2k

Countries citing papers authored by G. Mickisch

Since Specialization

Citations

This map shows the geographic impact of G. Mickisch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Mickisch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Mickisch more than expected).

Fields of papers citing papers by G. Mickisch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Mickisch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Mickisch. The network helps show where G. Mickisch may publish in the future.

Co-authorship network of co-authors of G. Mickisch

This figure shows the co-authorship network connecting the top 25 collaborators of G. Mickisch. A scholar is included among the top collaborators of G. Mickisch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Mickisch. G. Mickisch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Miller, K., Peter Albers, Marc‐Oliver Grimm, et al.. (2014). Metastasiertes kastrationsresistentes Prostatakarzinom. Der Urologe. 53(5). 710–714. 3 indexed citations

Melichar, Bohuslav, Sergio Bracarda, В. Б. Матвеев, et al.. (2013). A multinational phase II trial of bevacizumab with low-dose interferon-α2a as first-line treatment of metastatic renal cell carcinoma: BEVLiN. Annals of Oncology. 24(9). 2396–2402. 24 indexed citations

Gore, Martin, Joaquim Bellmunt, Tim Eisen, et al.. (2012). Evaluation of treatment options for patients with advanced renal cell carcinoma: Assessment of appropriateness, using the validated semi-quantitative RAND corporation/University of California, Los Angeles methodology. European Journal of Cancer. 48(7). 1038–1047. 13 indexed citations

Mickisch, G., M. Gore, Bernard Escudier, et al.. (2009). Costs of managing adverse events in the treatment of first-line metastatic renal cell carcinoma: bevacizumab in combination with interferon-α2a compared with sunitinib. British Journal of Cancer. 102(1). 80–86. 54 indexed citations

Malkowicz, S. Bruce, Hendrik Van Poppel, G. Mickisch, et al.. (2007). Muscle-Invasive Urothelial Carcinoma of the Bladder. Urology. 69(1). 3–16. 134 indexed citations

Jockenhövel, F., et al.. (2005). The good, the bad, and the unknown of late onset hypogonadism: the urological perspective. The Journal of Men s Health and Gender. 2(3). 292–301. 4 indexed citations

Albrecht, W., Hendrik Van Poppel, Simon Horenblas, et al.. (2004). Randomized Phase II trial assessing estramustine and vinblastine combination chemotherapy vs estramustine alone in patients with progressive hormone-escaped metastatic prostate cancer. British Journal of Cancer. 90(1). 100–105. 29 indexed citations

Brussel, J.P. van & G. Mickisch. (2003). Multidrug Resistance in Prostate Cancer. Oncology Research and Treatment. 26(2). 175–181. 59 indexed citations

Mickisch, G.. (2003). Rational Selection of a Control Arm for Randomised Trials in Metastatic Renal Cell Carcinoma. European Urology. 43(6). 670–679. 16 indexed citations

10.

Mickisch, G.. (2002). Multimodality treatment of metastatic renal cell carcinoma. Expert Review of Anticancer Therapy. 2(6). 681–685. 5 indexed citations

11.

Kurth, Karl H., et al.. (2001). Renal, bladder, prostate and testicular cancer : an update : the proceedings of the VI Congress on Progress and Controversies in Oncological Urology (PACIOU VI), held in Rotterdam, the Netherlands, October 2000. 2 indexed citations

12.

Mickisch, G.. (2001). Early versus Deferred Hormonal Treatment for Asymptomatic Prostate Cancer. Oncology Research and Treatment. 24(3). 214–220. 5 indexed citations

13.

Mickisch, G., Joaquı́n Carballido, Sverker Hellsten, Harald Schulze, & Han J.A. Mensink. (2001). Guidelines on Renal Cell Cancer. European Urology. 40(3). 252–255. 95 indexed citations

14.

Brussel, J.P. van, et al.. (2000). A phase II study of temozolomide in hormone-refractory prostate cancer. Cancer Chemotherapy and Pharmacology. 45(6). 509–512. 26 indexed citations

15.

Mickisch, G.. (2000). Prognostic parameters for the management of advanced testis tumours. Current Opinion in Urology. 10(5). 465–471. 7 indexed citations

16.

Albrecht, Walter, Simon Horenblas, J Maréchal, et al.. (1999). Randomized Phase II trial assessing estramustine and vinblastine combination chemotherapy vs estramustine alone in patients with progressive hormone-escaped metastatic prostate cancer. The Journal of Urology. 161(4). 298–298. 2 indexed citations

17.

Brussel, J.P. van, G.J. van Steenbrugge, J.C. Romijn, Fritz H. Schröder, & G. Mickisch. (1999). Chemosensitivity of prostate cancer cell lines and expression of multidrug resistance-related proteins. European Journal of Cancer. 35(4). 664–671. 91 indexed citations

18.

Mickisch, G.. (1995). Gene therapy on renal-cell carcinoma: magic bullet or tragic insanity?. World Journal of Urology. 13(3). 178–185. 6 indexed citations

19.

Mickisch, G.. (1994). Chemoresistance of renal cell carcinoma: 1986?1994. World Journal of Urology. 12(4). 214–23. 20 indexed citations

20.

Mickisch, G., Ira Pastan, & Michael M. Gottesman. (1991). Multidrug resistant transgenic mice as a novel pharmacologic tool. BioEssays. 13(8). 381–387. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact